Figure 2.
Validation of AMLlnc69. (A-B) KM survival curve of RFS (A) and OS (B) of patients with pedAML in the low- and high-risk groups. (C) ROC curves and AUCs for 1-, 2-, and 3-year RFS.
Validation of AMLlnc69. (A-B) KM survival curve of RFS (A) and OS (B) of patients with pedAML in the low- and high-risk groups. (C) ROC curves and AUCs for 1-, 2-, and 3-year RFS.
